384 related articles for article (PubMed ID: 35883693)
1. Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities.
Wang YT; Lu JH
Cells; 2022 Jul; 11(14):. PubMed ID: 35883693
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
3. Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy.
Liu Y; Tan L; Tan MS
Mol Cell Biochem; 2023 Oct; 478(10):2173-2190. PubMed ID: 36695937
[TBL] [Abstract][Full Text] [Related]
4. Chaperone-Mediated Autophagy in Neurodegenerative Diseases and Acute Neurological Insults in the Central Nervous System.
Kanno H; Handa K; Murakami T; Aizawa T; Ozawa H
Cells; 2022 Apr; 11(7):. PubMed ID: 35406769
[TBL] [Abstract][Full Text] [Related]
5. Chaperone-Mediated Autophagy and Its Emerging Role in Hematological Malignancies.
Robert G; Jacquel A; Auberger P
Cells; 2019 Oct; 8(10):. PubMed ID: 31623164
[TBL] [Abstract][Full Text] [Related]
6. Chaperone-mediated autophagy and neurodegeneration: connections, mechanisms, and therapeutic implications.
Liu X; Huang S; Wang X; Tang B; Li W; Mao Z
Neurosci Bull; 2015 Aug; 31(4):407-15. PubMed ID: 26206600
[TBL] [Abstract][Full Text] [Related]
7. Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases.
Xilouri M; Stefanis L
Mol Cell Neurosci; 2015 May; 66(Pt A):29-36. PubMed ID: 25724482
[TBL] [Abstract][Full Text] [Related]
8. Chaperone-mediated autophagy dysregulation during aging impairs hepatic fatty acid oxidation via accumulation of NCoR1.
Choi YJ; Yun SH; Yu J; Mun Y; Lee W; Park CJ; Han BW; Lee BH
Mol Metab; 2023 Oct; 76():101784. PubMed ID: 37524243
[TBL] [Abstract][Full Text] [Related]
9. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
10. Modulating Chaperone-Mediated Autophagy and Its Clinical Applications in Cancer.
Hubert V; Weiss S; Rees AJ; Kain R
Cells; 2022 Aug; 11(16):. PubMed ID: 36010638
[TBL] [Abstract][Full Text] [Related]
11. Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells.
Desideri E; Castelli S; Dorard C; Toifl S; Grazi GL; Ciriolo MR; Baccarini M
Autophagy; 2023 Jan; 19(1):152-162. PubMed ID: 35435804
[TBL] [Abstract][Full Text] [Related]
12. Chaperone-Mediated Autophagy: A Potential Target for Metabolic Diseases.
Yang M; Luo S; Chen W; Zhao L; Wang X
Curr Med Chem; 2023; 30(16):1887-1899. PubMed ID: 35959621
[TBL] [Abstract][Full Text] [Related]
13. Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.
Cacciottolo M; Nogalska A; D'Agostino C; Engel WK; Askanas V
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):750-61. PubMed ID: 23452232
[TBL] [Abstract][Full Text] [Related]
14. The Role of Chaperone-Mediated Autophagy in Hepatitis C Virus-Induced Pathogenesis.
Matsui C; Yuliandari P; Deng L; Abe T; Shoji I
Front Cell Infect Microbiol; 2021; 11():796664. PubMed ID: 34926330
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.
Matsui C; Deng L; Minami N; Abe T; Koike K; Shoji I
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695419
[TBL] [Abstract][Full Text] [Related]
16. Dysfunction of chaperone-mediated autophagy in human diseases.
Liao Z; Wang B; Liu W; Xu Q; Hou L; Song J; Guo Q; Li N
Mol Cell Biochem; 2021 Mar; 476(3):1439-1454. PubMed ID: 33389491
[TBL] [Abstract][Full Text] [Related]
17. SNX10-mediated degradation of LAMP2A by NSAIDs inhibits chaperone-mediated autophagy and induces hepatic lipid accumulation.
Lee W; Kim HY; Choi YJ; Jung SH; Nam YA; Zhang Y; Yun SH; Chang TS; Lee BH
Theranostics; 2022; 12(5):2351-2369. PubMed ID: 35265214
[No Abstract] [Full Text] [Related]
18. Chaperone-mediated autophagy protects cardiomyocytes against hypoxic-cell death.
Ghosh R; Gillaspie JJ; Campbell KS; Symons JD; Boudina S; Pattison JS
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1555-C1575. PubMed ID: 35584327
[TBL] [Abstract][Full Text] [Related]
19. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
20. The role of chaperone-mediated autophagy in neurotoxicity induced by alpha-synuclein after methamphetamine exposure.
Sun L; Lian Y; Ding J; Meng Y; Li C; Chen L; Qiu P
Brain Behav; 2019 Aug; 9(8):e01352. PubMed ID: 31286692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
